Table 1.

Sociodemographic and Disease-Specific Characteristics of Sample

Variable	Symptom Cluster			Total
	Asymptomatic	Symptomatic	Fatigue
Gender (%)
Male	71	67	75	72
Female	29	33	25	28
Age (years)*
Mean	67.5	60.4	67.5	65
Range	30–90	22–84	31–88	22–90
Ethnicity (%)a
Caucasian	91	94	90	91
African American	5	2	7	6
Asian/Pacific Islander	3	6	2	2
Hispanic	1	0	1	1
Diagnosis (%)
Hepatocellular	88	75	87	84
Cholangio	3	9	6	5
Neuroendocrine	1	4	3	3
Gallbladder	4	10	4	6
Liver metastases	4	2	0	2
Hepatitis (%)b
B	7.6	5.9	1.4	6
C	24.1	17.6	19.2	28
B and C	3.8	5.9	9.6	8
Cirrhosis (%)b	57	49	60	45
Tumor Size (cm)
Median	5	6.2	6	7
Range	0.9–21	1–22	0–18	0.5–22
Number of Lesions
Median	2	3	2	3
Range	1–6	1–6	1–6	1–6
Vascular invasion (%)	25.3	27.5	35.6	24
Vascularity (%)
Hypervascular	78	74	79	77
Hypovascular	20	15	17	17
Mixed	2	10	4	6
Treatment (%)
Transarterial Infusion
Chemotherapy	80	83	69	77
90-Yttrium	20	17	30	23
Survival (months)
Median	9.9	8.8	7.5	8
Range	0.4–52	0.9–63.5	0.8–91.2	0.4–91.2

^aP<0.001.

^bP<0.01.